Sigachi Industries Limited (SIGACHI.BO)
INR 37.71
(4.63%)
INR 37.71
(4.63%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 859.94 Million INR | 57.12% |
| 2022 | 547.3 Million INR | 839.97% |
| 2021 | 58.22 Million INR | 15.81% |
| 2020 | 50.27 Million INR | -76.75% |
| 2019 | 216.23 Million INR | -9.81% |
| 2018 | 239.76 Million INR | -18.51% |
| 2017 | 294.22 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | 1.11 Billion INR | 2941.74% |
| 2023 Q2 | 36.58 Million INR | -88.83% |
| 2023 FY | 859.94 Million INR | 57.12% |
| 2023 Q4 | 859.94 Million INR | -22.71% |
| 2023 Q1 | 327.55 Million INR | -40.15% |
| 2022 FY | 547.3 Million INR | 839.97% |
| 2022 Q3 | 239.07 Million INR | -60.0% |
| 2022 Q2 | 597.68 Million INR | -13.86% |
| 2022 Q1 | 693.82 Million INR | 1091.61% |
| 2022 Q4 | 547.3 Million INR | 128.92% |
| 2021 Q1 | 145.95 Million INR | 190.29% |
| 2021 FY | 58.22 Million INR | 15.81% |
| 2021 Q4 | 58.22 Million INR | -54.12% |
| 2021 Q3 | 126.91 Million INR | -32.78% |
| 2021 Q2 | 188.79 Million INR | 29.36% |
| 2020 Q4 | 50.27 Million INR | 0.0% |
| 2020 FY | 50.27 Million INR | -76.75% |
| 2020 Q1 | 105.89 Million INR | 0.0% |
| 2019 FY | 216.23 Million INR | -9.81% |
| 2018 FY | 239.76 Million INR | -18.51% |
| 2017 FY | 294.22 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 77.756% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 76.716% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 130.252% |
| Granules India Limited | 9.28 Billion INR | 90.74% |
| Indoco Remedies Limited | 6.47 Billion INR | 86.722% |
| Achyut Healthcare Limited | -3.74 Million INR | 23056.46% |
| Ajanta Pharma Limited | -954.9 Million INR | 190.056% |
| Alkem Laboratories Limited | -1.6 Billion INR | 153.433% |
| Alpa Laboratories Limited | 35.36 Million INR | -2331.776% |
| Brooks Laboratories Limited | 49.48 Million INR | -1637.797% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 117.156% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 73.933% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 174.277% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 93.34% |
| Eris Lifesciences Limited | 13.8 Billion INR | 93.771% |
| FDC Limited | -57.75 Million INR | 1589.038% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 120.068% |
| Gufic Biosciences Limited | 3.19 Billion INR | 73.079% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 120.706% |
| Ipca Laboratories Limited | 11.41 Billion INR | 92.467% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 161.87% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 55.51% |
| Lasa Supergenerics Limited | 205.79 Million INR | -317.859% |
| Laurus Labs Limited | 24.38 Billion INR | 96.473% |
| Lupin Limited | 17.19 Billion INR | 94.998% |
| Mankind Pharma Limited | -9.9 Billion INR | 108.679% |
| Medicamen Biotech Limited | 160.31 Million INR | -436.409% |
| Medico Remedies Limited | 78.67 Million INR | -993.012% |
| Megasoft Limited | 1.28 Billion INR | 33.107% |
| NATCO Pharma Limited | -5.81 Billion INR | 114.783% |
| Piramal Pharma Limited | 42.27 Billion INR | 97.966% |
| RPG Life Sciences Limited | -364.7 Million INR | 335.796% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 101.187% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -493.166% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -1760.918% |
| Unichem Laboratories Limited | 931.91 Million INR | 7.722% |
| Wanbury Limited | 1.1 Billion INR | 22.238% |
| Windlas Biotech Limited | -273.04 Million INR | 414.953% |
| ZIM Laboratories Limited | 983.6 Million INR | 12.572% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 78.018% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 191.309% |
| Divi's Laboratories Limited | -39.77 Billion INR | 102.162% |
| Hester Biosciences Limited | 2.29 Billion INR | 62.46% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 136.625% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 445.65% |
| Bal Pharma Limited | 1.26 Billion INR | 31.942% |
| Strides Pharma Science Limited | 23.25 Billion INR | 96.302% |
| Venus Remedies Limited | -267.7 Million INR | 421.236% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 67.076% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 86.034% |
| Shilpa Medicare Limited | 9.06 Billion INR | 90.518% |
| Aarti Drugs Limited | 5.54 Billion INR | 84.501% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 178.085% |
| Suven Life Sciences Limited | -1.63 Billion INR | 152.67% |
| Ind-Swift Limited | 9.5 Billion INR | 90.956% |
| Valiant Laboratories Limited | -295.03 Million INR | 391.477% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 69.518% |
| Solara Active Pharma Sciences Limited | 10.02 Billion INR | 91.425% |
| Themis Medicare Limited | 764.96 Million INR | -12.417% |
| Hikal Limited | 7.96 Billion INR | 89.206% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 97.298% |
| Sequent Scientific Limited | 4.17 Billion INR | 79.42% |
| Novartis India Limited | -5.89 Billion INR | 114.597% |
| Wockhardt Limited | 18.27 Billion INR | 95.293% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 96.823% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 4761.981% |
| Neuland Laboratories Limited | -214.05 Million INR | 501.736% |
| Morepen Laboratories Limited | -231.17 Million INR | 471.992% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -616.391% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | 11.873% |